Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [356]
News [1751]
Articles [86]
Editorials [3]
Conferences [74]
elearning [15]

New drug advancements presented at ASCO

Dr Christian Rolfo – Antwerp University, Belgium
New drug advancements presented at ASCO ( Dr Christian Rolfo – Antwerp University, Belgium )
21 Jul 2017

iManageCancer: Psycho-emotional and family resilience monitoring

Dr Chiara Renzi - European Institute of Oncology, Milan, Italy
iManageCancer: Psycho-emotional and family resilience monitoring ( Dr Chiara Renzi - European Institute of Oncology, Milan, Italy )
21 Jul 2017

Celebrating a 10 year partnership: ecancer and the IEO

Prof Gordon McVie - Editor in Chief, ecancer
Celebrating a 10 year partnership: ecancer and the IEO ( Prof Gordon McVie - Editor in Chief, ecancer )
19 Jul 2017

Improving care for cancer patients

Dr David Hui - MD Anderson Cancer Center, Houston, USA
Improving care for cancer patients ( Dr David Hui - MD Anderson Cancer Center, Houston, USA )
14 Jun 2017

Managing cancer and living meaningfully

Dr Gary M. Rodin - UHN Princess Margaret Hospital, Toronto, Canada
Managing cancer and living meaningfully ( Dr Gary M. Rodin - UHN Princess Margaret Hospital, Toronto, Canada )
14 Jun 2017

Stereotactic radiotherapy in primary hepatic cancer

Dr Parag Parikh - Washington University, St. Louis, USA
Stereotactic radiotherapy in primary hepatic cancer ( Dr Parag Parikh - Washington University, St. Louis, USA )
13 Jun 2017

Tivantinib as second line therapy for high-MET HCC

Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy
Tivantinib as second line therapy for high-MET HCC ( Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy )
4 Jun 2017

Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours

Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA
Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours ( Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Apr 2017

Neratinib in HER2 or HER3 mutant solid tumours

Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA
Neratinib in HER2 or HER3 mutant solid tumours ( Dr David Hyman - Memorial Sloan Kettering Cancer Center, New York, USA )
10 Apr 2017

Existing and prospective immunotherapeutics for biliary tract cancer

Prof Junji Furuse - Kyorin University Hospital Cancer Centre, Tokyo, Japan
Existing and prospective immunotherapeutics for biliary tract cancer ( Prof Junji Furuse - Kyorin University Hospital Cancer Centre, Tokyo, Japan )
3 Jan 2017

Promising partners for check-point immunotherapy for HCC?

Dr Stephen Chan - The Chinese University of Hong Kong, Hong Kong
Promising partners for check-point immunotherapy for HCC? ( Dr Stephen Chan - The Chinese University of Hong Kong, Hong Kong )
3 Jan 2017

Personalised therapy for gastric and pancreatic cancer

Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany
Personalised therapy for gastric and pancreatic cancer ( Prof Salah-Eddin Al-Batran - University Cancer Center, Frankfurt, Germany )
21 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation